V8M (p.Val8Met) variant of ACTN2 (Alpha-actinin-2)

V8M (p.Val8Met) in ACTN2 (Alpha-actinin-2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of Dilated cardiomyopathy 1AA; Primary familial hypertrophic cardiomyopathy; not sp. The available variant effect predictions contribute to a CATVariant prioritization score of 0.41 / 1. The record also includes population frequency data, published literature, and structural context.

V8M (p.Val8Met) variant details